Lux submits Luveniq NDA, MAA

Lux Biosciences Inc. (Jersey City, N.J.) submitted an NDA to FDA and an MAA to the European Medicines Agency (EMA) for Luveniq voclosporin ( LX211) to treat non-infectious uveitis in the intermediate ...